Loading
Loading…
New
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | MAHAVIR PHARMACEUTICALS | Awarded | 1 | ₹19,440 |
| 2 | Schedule 2 | SMPL LIFE SCIENCES PRIVATE LIMITED | Awarded | 1 | ₹16,934.40 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
2 Jul 2025, 11:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Akt-4 (Isoniazid 300mg+ Rifampicin(450mg) + Ethambutol(800mg) + Pyrazinamide(750mg)
Cabozantinib 20 Mg Tab
7952034
GEM/2025/B/6331312
Two Packet Bid
Akt-4 (Isoniazid 300mg+ Rifampicin(450mg) +
15 days
Central Delhi
Item wise evaluation
PRODUCT_CUSTOM
7 documents required · 7 mandatory
3 yrs
10%
Exempted
2 Jul 2025
11 Jun 2025
2 Jul 2025
Akt-4 (Isoniazid 300mg+ Rifampicin(450mg) + Ethambutol(800mg) + Pyrazinamide(750mg)
Cabozantinib 20 Mg Tab
CABOZANTINIB 20 MG TAB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7952034.pdf
GEM_BID
specification_re-25_2025-06-11-10-08-23_9f1a73f93f3920bd5363dc4561c4d548.pdf
SPECIFICATION
specification_re-25_2025-06-11-10-09-24_62301c682cde268421fb306b10a13f42.pdf
SPECIFICATION
newatc_ae8e86e9-3c67-43c3-92b31749617644752_sauravroy.148l@gov.in.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .